<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Breast cancer":72,
"Prognosis":61,
"long noncoding RNA":3,
"Anaplastic thyroid carcinoma":24,
"Distant metastases":4,
"Poorly differentiated thyroid carcinoma":5,
"Biopsy":7,
"Core-needle biopsy":5,
"Fine-needle aspiration biopsy":5,
"endoscopic":4,
"thyroidectomy":69,
"Thyroid malignancy":4,
"Thyroid nodule":75,
"Thyroid cancer":287,
"fine-needle aspiration":39,
"thyroid nodules":48,
"thyroid surgery":15,
"Case-control studies":4,
"Risk factors":16,
"Smoking":4,
"Thyroid neoplasms":92,
"TSH":7,
"nodular goiter":6,
"thyroid gland":20,
"HISTOPATHOLOGY":6,
"MOLECULAR PATHOLOGY":5,
"Radioactive iodine therapy":5,
"Total thyroidectomy":14,
"Voice":4,
"Well-differentiated thyroid cancer":6,
"Nasopharynx":3,
"histology":7,
"neuroendocrine carcinoma":3,
"parotid gland":3,
"survival":21,
"I-131":4,
"predictive factors":3,
"thyroglobulin":26,
"BRAF":24,
"lncRNA":5,
"migration":17,
"papillary thyroid cancer":74,
"proliferation":32,
"Hematoma":5,
"Endoscopic thyroidectomy":9,
"Transaxillary":4,
"Hypothyroidism":24,
"prognostic factor":3,
"surgery":29,
"Medullary thyroid carcinoma":35,
"Molecular biology":4,
"Papillary thyroid carcinoma":173,
"Elastography":10,
"Guidelines":4,
"Prostate cancer":7,
"Shear wave elastography":4,
"Carcinoma":15,
"Immunohistochemistry":48,
"Lung":9,
"pediatric":8,
"CXCR2":3,
"Cancer stem cells":8,
"Vitamin D":6,
"Thyrotropin":6,
"cytology":26,
"thyroid":150,
"RET":12,
"RET/PTC":5,
"cabozantinib":12,
"non-small cell lung cancer":6,
"vandetanib":7,
"Differentiated thyroid cancer":50,
"Remnant ablation":4,
"Cancer":71,
"Incidence":18,
"Obesity":5,
"Classification":4,
"Convolutional neural network":4,
"Diagnosis":30,
"Ultrasound image":3,
"Cowden syndrome":5,
"Neoplasm metastasis":9,
"complications":8,
"pediatrics":3,
"recurrence":33,
"Angiogenesis":3,
"Glioblastoma":3,
"BRAF mutation":16,
"Warburg effect":3,
"glycolysis":5,
"molecular markers":6,
"thyroid hormone":6,
"thyrotoxicosis":4,
"metastasis":49,
"thyroid neoplasm":14,
"central neck dissection":8,
"disease-free survival":9,
"reoperation":4,
"response to therapy":3,
"meta-analysis":31,
"Iodine radioisotopes":4,
"PET/CT":7,
"follicular neoplasm":10,
"indeterminate":4,
"positron emission tomography":6,
"Lymph node metastasis":28,
"treatment":16,
"TP53":4,
"anaplastic thyroid cancer":18,
"mutation":9,
"papillary carcinoma":25,
"antithyroglobulin antibody":3,
"follicular adenoma":5,
"follicular thyroid cancer":7,
"tissue microarray":5,
"medullary thyroid cancer":26,
"galectin-3":4,
"indeterminate cytology":6,
"Ectopic thyroid":3,
"Glioma":4,
"Quality of life":11,
"Thyroid hormones":7,
"Tri-iodothyronine":3,
"Pediatric thyroid cancer":4,
"adverse events":5,
"neoplasia":5,
"parathyroid":5,
"thyroid carcinoma":81,
"miR-375":3,
"MicroRNA":10,
"BRAF V600E":8,
"Differentiated thyroid carcinoma":18,
"Radioiodine therapy":13,
"invasion":28,
"BRAF V600E mutation":5,
"RAS mutation":4,
"TERT promoter mutation":4,
"drug resistance":5,
"epithelial-mesenchymal transition":6,
"HCC":4,
"hypertension":5,
"sorafenib":15,
"Differential diagnosis":6,
"Tumor":3,
"fine-needle aspiration cytology":8,
"ultrasound":55,
"biomarker":20,
"ultrasonography":45,
"Renal cell carcinoma":11,
"mTOR":3,
"SEER Program":3,
"metformin":4,
"outcomes":8,
"tumorigenesis":8,
"Apoptosis":20,
"Autophagy":7,
"Capecitabine":3,
"Chemotherapy":14,
"Gastric cancer":9,
"head and neck ultrasound":6,
"genomics":5,
"radiation therapy":8,
"sarcoma":3,
"cancer biology":4,
"cell migration":4,
"clinicopathological features":3,
"tall cell variant":6,
"chemoradiotherapy":4,
"pancreatic cancer":5,
"BRAFV600E":5,
"genetics":4,
"miRNA":5,
"variants":3,
"PKM2":11,
"tumor growth":3,
"IHC":3,
"head and neck cancer":10,
"Lung cancer":15,
"age":4,
"mortality":16,
"meningioma":4,
"Endoscopy":3,
"Graves’ disease":5,
"Reconstruction":3,
"Case report":11,
"Radioiodine":15,
"SPECT/CT":3,
"Lenvatinib":18,
"Thyroxine":4,
"FNA":7,
"Radiation":9,
"Genetic testing":3,
"Overdiagnosis":10,
"Computed tomography":6,
"Incidentaloma":3,
"lymph node dissection":5,
"PIK3CA":3,
"Papillary thyroid microcarcinoma":15,
"cohort studies":3,
"review":8,
"Bethesda system":4,
"female":4,
"nonsmall cell lung carcinoma":3,
"thyroid metastasis":3,
"follicular variant":10,
"terminology":4,
"DNA methylation":4,
"follow-up":6,
"Fine needle cytology":5,
"Hemithyroidectomy":4,
"Calcitonin":13,
"Cancer registry":4,
"Iodine":8,
"Thyroid tumor":7,
"atypia of undetermined significance":5,
"fine needle aspiration":21,
"follicular lesion of undetermined significance":3,
"risk of malignancy":4,
"Core needle biopsy":8,
"Malignancy":11,
"Neoplasm":4,
"Robotic thyroidectomy":5,
"EZH2":3,
"Frozen section":4,
"Risk stratification":7,
"radiotherapy":17,
"renal cell cancer":3,
"mesothelioma":3,
"squamous cell carcinoma":11,
"Thermal ablation":12,
"radiofrequency/microwave":3,
"Adult":6,
"Parathyroid gland":5,
"Parathyroidectomy":8,
"Autoimmune thyroiditis":5,
"Thyroid disease":9,
"Acromegaly":4,
"TTF1":3,
"Follicular":4,
"Overall survival":9,
"Thyroid lobectomy":3,
"PTEN":9,
"vascular endothelial growth factor":6,
"Ganglioneuroma":3,
"paraganglioma":8,
"radioactive iodine-refractory thyroid cancer":3,
"multifocality":4,
"second primary cancer":5,
"RAS":11,
"papillary":10,
"cell cycle":5,
"gene expression":7,
"epidemiology":20,
"children":12,
"mutations":4,
"clinical research":3,
"Molecular diagnosis":3,
"SEER":9,
"Benign thyroid nodule":9,
"Microwave ablation":3,
"Radiofrequency ablation":10,
"sonography":6,
"cervical lymph node metastasis":4,
"fine needle aspiration cytology":6,
"single nucleotide polymorphism":4,
"fine-needle aspiration (FNA)":6,
"Adenocarcinoma":7,
"Hyperthyroidism":11,
"Nodule":5,
"Triiodothyronine":6,
"TERT":7,
"telomerase":3,
"hobnail":3,
"next-generation sequencing":7,
"neuroendocrine tumor":4,
"PDL1":3,
"Hashimoto’s thyroiditis":9,
"cervical lymph nodes":3,
"metastases":8,
"radiology":4,
"Colorectal cancer":7,
"Nodules":3,
"EMT":6,
"doxorubicin":5,
"synergism":4,
"Thyroid transcription factor 1":3,
"Immunotherapy":13,
"Nivolumab":6,
"caveolin-1":3,
"oncogene":5,
"Spindle cell oncocytoma":3,
"Trachea":6,
"Prophylactic central neck dissection":7,
"cN0":3,
"Vemurafenib":3,
"Calcification":4,
"Advanced thyroid cancer":3,
"Tyrosine kinase inhibitor":5,
"dabrafenib":3,
"radioactive iodine":13,
"cirrhosis":3,
"Oncology":11,
"fine needle aspiration biopsy":6,
"Bilateral axillo-breast approach":4,
"Lymphadenectomy":4,
"Central lymph node metastasis":7,
"Long non-coding RNA":5,
"MALAT1":5,
"RT-PCR":3,
"Pleuropulmonary blastoma":4,
"Targeted therapy":12,
"cohort study":6,
"Papillary thyroid carcinoma (PTC)":8,
"Hypocalcemia":5,
"Hypoparathyroidism":5,
"Tiroides":3,
"Cáncer de tiroides":3,
"EGFR":4,
"pregnancy":8,
"Chronic lymphocytic thyroiditis":3,
"Head and neck":4,
"Breast Neoplasms":7,
"Goiter":7,
"Autoimmune thyroid disease":4,
"PD-1":4,
"pembrolizumab":4,
"thyroid dysfunction":3,
"Melanoma":5,
"oncocytic":3,
"molecular diagnostics":3,
"Familial cancer":4,
"HABP2":3,
"Biomarkers":8,
"thyroid cytology":4,
"Metabolomics":5,
"Intraoperative neuromonitoring":3,
"hepatocellular carcinoma":14,
"Biopsy, fine-needle":3,
"Diagnostic accuracy":3,
"Hashimoto thyroiditis":4,
"disease progression":3,
"Her2":3,
"NF-κB":3,
"Adolescents":7,
"Lymph node":10,
"pathology":12,
"TIRADS":3,
"Thyroid incidentaloma":5,
"incidental findings":5,
"Papillary thyroid cancer (PTC)":3,
"Therapy":5,
"Lymph nodes":7,
"Lymphatic metastasis":8,
"childhood cancer":3,
"Head and neck neoplasms":8,
"anxiety":4,
"sunitinib":5,
"Neuroendocrine Tumors":7,
"Neoplasms":13,
"Metabolism":4,
"Follicular thyroid carcinoma":12,
"Head and neck surgery":4,
"TGF-β1":3,
"next generation sequencing":4,
"Consensus":4,
"Thyroid ultrasound":7,
"endocrinology":5,
"struma ovarii":3,
"extrathyroidal extension":9,
"prognostic factors":3,
"Lung adenocarcinoma":6,
"Metastatic lymph node":3,
"endocrine":5,
"integrin αvβ3":3,
"ovarian cancer":3,
"Contrast-enhanced ultrasound":3,
"TI-RADS":3,
"immunocytochemistry":3,
"Pituicytoma":3,
"TTF-1":8,
"Parathyroid carcinoma":6,
"survival analysis":4,
"Breast":3,
"dynamic risk stratification":5,
"solid variant":4,
"Lymph node metastases":4,
"Neck dissection":22,
"discordant cancer":3,
"familial risk":3,
"outcome":7,
"China":6,
"population-based":5,
"bone":5,
"131I":4,
"ipilimumab":4,
"NIFTP":9,
"follicular variant of papillary thyroid carcinoma":4,
"molecular testing":8,
"ATA guidelines":3,
"Bethesda":10,
"active surveillance":5,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":10,
"distant metastasis":6,
"cell proliferation":4,
"Afirma":3,
"Bethesda classification":4,
"TERT promoter":3,
"relapse":3,
"Thyroid cancer, papillary":3,
"anaplastic":4,
"medullary":3,
"molecular":5,
"2017":3,
"Korea":3,
"Progression-free survival":6,
"adrenocortical carcinoma":3,
"PD-L1":4,
"PTC":9,
"Indeterminate thyroid nodules":7,
"gene expression classifier":3,
"Lymphoma":6,
"Ki-67":4,
"p53":3,
"Colon cancer":3,
"Carcinoma, papillary":11,
"Thyroid papillary carcinoma":4,
"multiple endocrine neoplasia type 2":3,
"imaging":5,
"management":3,
"PSMA":3,
"pheochromocytoma":5,
"primary hyperparathyroidism":9,
"Follicular carcinoma":5,
"Minimally invasive":3,
"NSCLC":5,
"somatostatin analogues":3,
"Thyroiditis":3,
"Venous Thromboembolism":4,
"Indocyanine green":3,
"β-catenin":4,
"Immune checkpoint inhibitors":4,
"Toxicity":3,
"Tyrosine kinase inhibitors":6,
"lobectomy":3,
"Laryngectomy":3,
"Larynx":4,
"Liquid-based cytology":3,
"Thyroid lesions":3,
"dosimetry":6,
"radionuclide therapy":3,
"Cytopathology":6,
"DTC":3,
"Polymorphism":8,
"staging":3,
"aspiration cytology":4,
"CD56":3,
"recurrent laryngeal nerve":7,
"focused ultrasound":4,
"Surgical management":4,
"pharmacokinetics":3,
"Relative survival":3,
"Survivin":3,
"thyroid cartilage":4,
"Surveillance":3,
"endocrine cancer":5,
"BRAFV600E mutation":4,
"Children and adolescents":3,
"Lateral neck dissection":3,
"Morbidity":3,
"Magnetic resonance imaging":4,
"P63":4,
"MRI":3,
"fatigue":3,
"metastatic":3,
"Follow-up studies":3,
"Screening":7,
"safety":4,
"Mass spectrometry imaging":3,
"siRNA":3,
"Long-term survival":3,
"cytomorphology":3,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":3,
"CT":3,
"TNM staging":5,
"phaeochromocytoma":3,
"Acoustic radiation force impulse":3,
"tumor microenvironment":3,
"MAPK":5,
"Bisphenol A":5,
"qPCR":3,
"Survival rate":3,
"TKI":3,
"oncogenes":4,
"neuroendocrine tumours":4,
"Hyperparathyroidism":3,
"Parathyroid hormone":3,
"registries":3,
"papillary cancer":3,
"scintigraphy":3,
"Parathyroid glands":3,
"Proteomics":3,
"adequacy":3,
"AUS/FLUS":4,
"inflammation":4,
"clinical trials":3,
"mitochondria":3,
"VEGF":3,
"oxidative stress":3,
"Cyst":3,
"pituitary adenoma":6,
"Thyroid transcription factor-1":4,
"complication":3,
"Recurrent thyroid cancer":3,
"nodal metastasis":3,
"neck mass":3,
"Gene mutation":3,
"Cancer stem cell":3,
"Mass spectrometry":3,
"male":3,
"Thyroid diseases":3,
"public health":3,
"PSM":4,
"Triple-negative breast cancer":5,
"cardiovascular disease":3,
"carcinoid tumor":3,
"thyroid function":3,
"diagnostic value":3,
"Somatostatin":3            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
